Xiaoyue Yang, Ph.D., a postdoctoral scholar in the F. Joseph Halcomb III, M.D. Department of Biomedical Engineering Laboratory of Nanomedicine and Immunoengineering, has won a competitive National Institute of Biomedical Imaging and Bioengineering (NIBIB) Scholars Scientific Conference Travel Award.
Yang’s research is focused on developing innovative immunoengineering approach for cancer treatment. During her doctoral studies, Yang studied tumor neoantigen screening methodology and formulating plasmid-based cancer vaccines. After joining the Laboratory of Nanomedicine and Immunoengineering at the University of Kentucky, she has been developing an in vivo gene editing platform that initiates anticancer immune response by disrupting critical immune checkpoints. Her research to date has demonstrated significant tumor suppression effects in animal models, paving the way for a new generation of gene editing-based cancer therapy.
NIBIB offers 5-10 travel awards for undergraduate, postbaccalaureate, graduate students, postdoctoral fellows, and early-career investigators to defray the costs of attendance at scientific conferences. The goal of this award is to support the participation of individuals with a demonstrated interest in NIBIB-related research to attend scientific conferences and to meet with NIBIB staff to discuss research career and funding opportunities in biomedical engineering and biomedical imaging.
